After Z-score normalization and t-test analysis, there were significant differences in clinical factors, including preoperative TNM stage and tumor markers (CEA and CA19-9), between patients with liver metastases from CRC (the CRCLM group) and those without (the non-CRCLM group) (p < 0.05). Here, CEACAM5 is linked to neoplasm.